nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—Oxymetazoline—HTR2A—Gilles de la Tourette syndrome	0.0317	1	CrCbGaD
Xylometazoline—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00859	0.0603	CbGeAlD
Xylometazoline—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.0084	0.059	CbGeAlD
Xylometazoline—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00827	0.0581	CbGeAlD
Xylometazoline—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.00809	0.0568	CbGeAlD
Xylometazoline—HTR1B—midbrain—Gilles de la Tourette syndrome	0.00789	0.0554	CbGeAlD
Xylometazoline—HTR1D—midbrain—Gilles de la Tourette syndrome	0.00764	0.0536	CbGeAlD
Xylometazoline—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00731	0.00885	CbGpPWpGaD
Xylometazoline—ADRA2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00724	0.00876	CbGpPWpGaD
Xylometazoline—ADRA1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00712	0.00862	CbGpPWpGaD
Xylometazoline—ADRA2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00703	0.00851	CbGpPWpGaD
Xylometazoline—ADRA2B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00701	0.00848	CbGpPWpGaD
Xylometazoline—ADRA2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00699	0.00847	CbGpPWpGaD
Xylometazoline—ADRA1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00691	0.00837	CbGpPWpGaD
Xylometazoline—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00681	0.00824	CbGpPWpGaD
Xylometazoline—ADRA2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00679	0.00822	CbGpPWpGaD
Xylometazoline—ADRA1B—brain—Gilles de la Tourette syndrome	0.00656	0.0461	CbGeAlD
Xylometazoline—ADRA2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00654	0.00792	CbGpPWpGaD
Xylometazoline—HTR1B—nervous system—Gilles de la Tourette syndrome	0.00648	0.0455	CbGeAlD
Xylometazoline—ADRA1D—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00647	0.00783	CbGpPWpGaD
Xylometazoline—ADRA1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00644	0.0078	CbGpPWpGaD
Xylometazoline—ADRA1D—brain—Gilles de la Tourette syndrome	0.00642	0.0451	CbGeAlD
Xylometazoline—HTR1D—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00635	0.00769	CbGpPWpGaD
Xylometazoline—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00633	0.00766	CbGpPWpGaD
Xylometazoline—ADRA2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00632	0.00766	CbGpPWpGaD
Xylometazoline—HTR1D—nervous system—Gilles de la Tourette syndrome	0.00628	0.0441	CbGeAlD
Xylometazoline—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.00624	0.0439	CbGeAlD
Xylometazoline—HTR1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00622	0.00753	CbGpPWpGaD
Xylometazoline—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00614	0.00744	CbGpPWpGaD
Xylometazoline—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.00604	0.0425	CbGeAlD
Xylometazoline—ADRA2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00588	0.00712	CbGpPWpGaD
Xylometazoline—ADRA2B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00584	0.00707	CbGpPWpGaD
Xylometazoline—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00572	0.00693	CbGpPWpGaD
Xylometazoline—ADRA2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00571	0.00691	CbGpPWpGaD
Xylometazoline—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.00559	0.0393	CbGeAlD
Xylometazoline—ADRA2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00545	0.0066	CbGpPWpGaD
Xylometazoline—ADRA1D—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00544	0.00658	CbGpPWpGaD
Xylometazoline—ADRA1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00537	0.0065	CbGpPWpGaD
Xylometazoline—ADRA2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00532	0.00644	CbGpPWpGaD
Xylometazoline—HTR1B—brain—Gilles de la Tourette syndrome	0.00496	0.0348	CbGeAlD
Xylometazoline—ADRA2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00491	0.00594	CbGpPWpGaD
Xylometazoline—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.00482	0.0339	CbGeAlD
Xylometazoline—HTR1D—brain—Gilles de la Tourette syndrome	0.0048	0.0337	CbGeAlD
Xylometazoline—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00477	0.00577	CbGpPWpGaD
Xylometazoline—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.00464	0.0326	CbGeAlD
Xylometazoline—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.0046	0.0323	CbGeAlD
Xylometazoline—ADRA2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00458	0.00555	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00453	0.00549	CbGpPWpGaD
Xylometazoline—ADRA1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00451	0.00546	CbGpPWpGaD
Xylometazoline—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.00446	0.0313	CbGeAlD
Xylometazoline—ADRA2A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00443	0.00536	CbGpPWpGaD
Xylometazoline—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.00443	0.0311	CbGeAlD
Xylometazoline—ADRA1D—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0044	0.00533	CbGpPWpGaD
Xylometazoline—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00401	0.00485	CbGpPWpGaD
Xylometazoline—ADRA2A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00372	0.00451	CbGpPWpGaD
Xylometazoline—ADRA1A—brain—Gilles de la Tourette syndrome	0.00369	0.0259	CbGeAlD
Xylometazoline—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.00367	0.0258	CbGeAlD
Xylometazoline—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.00353	0.0248	CbGeAlD
Xylometazoline—ADRA2C—brain—Gilles de la Tourette syndrome	0.00351	0.0247	CbGeAlD
Xylometazoline—ADRA1D—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00287	0.00348	CbGpPWpGaD
Xylometazoline—ADRA2A—brain—Gilles de la Tourette syndrome	0.0028	0.0197	CbGeAlD
Xylometazoline—HTR1D—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00248	0.003	CbGpPWpGaD
Xylometazoline—HTR1B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00243	0.00294	CbGpPWpGaD
Xylometazoline—HTR1D—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00241	0.00292	CbGpPWpGaD
Xylometazoline—HTR1B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00236	0.00285	CbGpPWpGaD
Xylometazoline—HTR1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0023	0.00279	CbGpPWpGaD
Xylometazoline—HTR1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00225	0.00273	CbGpPWpGaD
Xylometazoline—HTR1D—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00224	0.00272	CbGpPWpGaD
Xylometazoline—HTR1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00223	0.00271	CbGpPWpGaD
Xylometazoline—HTR1B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.0022	0.00266	CbGpPWpGaD
Xylometazoline—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00219	0.00265	CbGpPWpGaD
Xylometazoline—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00208	0.00252	CbGpPWpGaD
Xylometazoline—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00204	0.00247	CbGpPWpGaD
Xylometazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00197	0.00239	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00197	0.00239	CbGpPWpGaD
Xylometazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00193	0.00234	CbGpPWpGaD
Xylometazoline—ADRA2B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00192	0.00232	CbGpPWpGaD
Xylometazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00191	0.00232	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00191	0.00232	CbGpPWpGaD
Xylometazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00187	0.00227	CbGpPWpGaD
Xylometazoline—ADRA2B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00186	0.00225	CbGpPWpGaD
Xylometazoline—ADRA2C—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00179	0.00217	CbGpPWpGaD
Xylometazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00178	0.00216	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00178	0.00216	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00178	0.00215	CbGpPWpGaD
Xylometazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00175	0.00211	CbGpPWpGaD
Xylometazoline—ADRA2C—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00174	0.0021	CbGpPWpGaD
Xylometazoline—ADRA2B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00173	0.0021	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00173	0.00209	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00169	0.00204	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00166	0.00201	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00164	0.00198	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00164	0.00198	CbGpPWpGaD
Xylometazoline—ADRA2C—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00162	0.00196	CbGpPWpGaD
Xylometazoline—ADRA1D—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00161	0.00195	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00161	0.00195	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00161	0.00195	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00159	0.00192	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00153	0.00185	CbGpPWpGaD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00152	0.00185	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0015	0.00182	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0015	0.00182	CbGpPWpGaD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00148	0.00179	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00148	0.00179	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00147	0.00178	CbGpPWpGaD
Xylometazoline—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00146	0.00177	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00146	0.00177	CbGpPWpGaD
Xylometazoline—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00145	0.00176	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00145	0.00176	CbGpPWpGaD
Xylometazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00144	0.00175	CbGpPWpGaD
Xylometazoline—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00143	0.00173	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00143	0.00173	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00142	0.00172	CbGpPWpGaD
Xylometazoline—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00141	0.00171	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00141	0.00171	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0014	0.0017	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00138	0.00167	CbGpPWpGaD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00138	0.00167	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00136	0.00165	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00136	0.00164	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00135	0.00163	CbGpPWpGaD
Xylometazoline—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00134	0.00162	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00133	0.00161	CbGpPWpGaD
Xylometazoline—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00132	0.00159	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00131	0.00159	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00131	0.00159	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00129	0.00156	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00129	0.00156	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00127	0.00153	CbGpPWpGaD
Xylometazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00125	0.00151	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00125	0.00151	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00125	0.00151	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00124	0.00151	CbGpPWpGaD
Xylometazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00122	0.00148	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00122	0.00148	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00121	0.00146	CbGpPWpGaD
Xylometazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0012	0.00145	CbGpPWpGaD
Xylometazoline—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00119	0.00144	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00116	0.00141	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00116	0.0014	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00116	0.0014	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00113	0.00136	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00113	0.00136	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00113	0.00136	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00112	0.00136	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00108	0.00131	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00107	0.00129	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00107	0.00129	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00106	0.00129	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00105	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00105	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00105	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00105	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	0.00104	0.00126	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00104	0.00125	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00104	0.00125	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00098	0.00119	CbGpPWpGaD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000965	0.00117	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000965	0.00117	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000951	0.00115	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000948	0.00115	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000931	0.00113	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00092	0.00111	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00092	0.00111	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000902	0.00109	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000887	0.00107	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00088	0.00107	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000857	0.00104	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000855	0.00103	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000855	0.00103	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000849	0.00103	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.000844	0.00102	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000831	0.00101	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000824	0.000998	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000814	0.000986	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000807	0.000977	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000796	0.000964	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000788	0.000954	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000771	0.000933	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000767	0.000929	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000755	0.000914	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000752	0.00091	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000748	0.000906	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000735	0.00089	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000733	0.000887	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000732	0.000887	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000726	0.000879	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000705	0.000854	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000697	0.000844	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000687	0.000831	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000682	0.000826	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000676	0.000818	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00066	0.000799	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000657	0.000795	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000656	0.000794	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00064	0.000775	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000637	0.000771	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000613	0.000742	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000603	0.00073	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.0006	0.000727	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000597	0.000722	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000595	0.000721	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000595	0.00072	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000593	0.000718	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000585	0.000709	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000578	0.0007	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000558	0.000675	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000556	0.000674	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000554	0.000671	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000547	0.000663	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000545	0.00066	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00054	0.000654	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000539	0.000652	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000538	0.000651	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000535	0.000648	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000531	0.000643	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000526	0.000637	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00052	0.000629	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000503	0.000609	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000498	0.000602	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000495	0.000599	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000488	0.000591	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000486	0.000589	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000484	0.000586	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000483	0.000585	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000478	0.000579	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000472	0.000572	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00046	0.000557	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000455	0.000551	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000452	0.000547	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00045	0.000545	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000446	0.00054	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000442	0.000535	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00044	0.000532	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000439	0.000531	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000433	0.000524	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000418	0.000506	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000415	0.000503	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000412	0.000499	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000409	0.000495	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000403	0.000488	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00039	0.000472	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000388	0.00047	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000382	0.000462	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000378	0.000458	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000377	0.000457	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000352	0.000427	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000352	0.000427	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000352	0.000426	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000347	0.00042	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000341	0.000413	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000339	0.000411	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000329	0.000398	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000323	0.000392	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000319	0.000386	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000318	0.000385	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000315	0.000382	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000314	0.00038	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000308	0.000373	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000297	0.00036	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000292	0.000354	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000288	0.000349	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000287	0.000348	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000286	0.000347	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000282	0.000342	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000279	0.000338	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000267	0.000323	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00026	0.000315	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000259	0.000314	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000247	0.000299	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000241	0.000292	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000223	0.00027	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000208	0.000252	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000205	0.000248	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000182	0.00022	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000169	0.000205	CbGpPWpGaD
